Current advances and future vision of drug delivery systems for cancer
Conventional cancer treatments often damage both tumour and healthy cells, leading to significant systemic toxicity. This has created an urgent need for the advancements of targeted drug delivery systems that can selectively reach cancer cells or tissues and release the drug precisely at the intended site. Recent advancements in anticancer therapy have highlighted the importance … Continued
Authors
- Luigi Alfano (ORCID: https://orcid.org/0000-0002-4516-9956)
- Annarita Falanga (ORCID: https://orcid.org/0000-0001-6538-8585)
- Stefania Galdiero (ORCID: https://orcid.org/0000-0002-7849-7024)
- Simone Braccia (ORCID: https://orcid.org/0009-0001-2927-705X)
- Silvano Palladino (ORCID: https://orcid.org/0009-0003-6255-8800)
- Rosa Bellavita (ORCID: https://orcid.org/0000-0003-2163-5163)
- Oluseyi Moses Ajayi (ORCID: https://orcid.org/0000-0002-5774-9034)
- Alessia Giordano (ORCID: https://orcid.org/0000-0002-3094-3830)
- Lorenzo Emiliano Imbò
Publication Details
- Journal
- Annals of Research in Oncology
- Published
- 2025-07-01
- DOI
- https://doi.org/10.48286/aro.2025.106
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Università degli Studi di Napoli Federico II
- Sbarro Health Research Organization
- European Commission